Nouveautés concernant l’asthme en médecine de premier recours [What's new on asthma in primary care]
Détails
Etat: Public
Version: Final published version
Licence: CC BY-NC-ND 4.0
ID Serval
serval:BIB_14908144FEA7
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Nouveautés concernant l’asthme en médecine de premier recours [What's new on asthma in primary care]
Périodique
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Statut éditorial
Publié
Date de publication
13/11/2019
Peer-reviewed
Oui
Volume
15
Numéro
671
Pages
2074-2079
Langue
français
Notes
Publication types: Journal Article ; Review
Publication Status: ppublish
Publication Status: ppublish
Résumé
The international recommendations of the management of asthma have been modified last years. Several therapies used since long time have no place in the management of moderate asthma today. The use of targeted immunotherapies against phenotypes of asthma are used more and more. Inhalant therapies are becoming more targeted towards the patient's wishes. This article specifies the novelties in management of asthma for de general practitioner, including the use of short acting beta2-agonists, which are no longer to be used without inhaled corticosteroid.
Mots-clé
Administration, Inhalation, Adrenal Cortex Hormones/administration & dosage, Adrenal Cortex Hormones/therapeutic use, Adrenergic beta-Agonists/administration & dosage, Adrenergic beta-Agonists/therapeutic use, Asthma/drug therapy, Asthma/therapy, Humans, Immunotherapy, Primary Health Care
Pubmed
Création de la notice
20/11/2019 22:53
Dernière modification de la notice
13/04/2024 6:08
Données d'usage
